drugset / Trial / NCT01796327
A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers
CrossoverOpen-labelBasic science
Summary
This study aims to determine the proportion of study drug dacomitinib or PF-00299804, that is taken up from the digestive tract into the body when given as an oral tablet compared with that taken up by an intravenous dose.
Timeline
- Start
- 2013-04
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DACOMITINIB ANHYDROUS | Small molecule | 20 mg | Oral |
| Subject | DACOMITINIB ANHYDROUS | Small molecule | 45 mg | Oral |
Indications
No indication recorded.